Vita Imaging is a medical-device company developing cancer detection and diagnostic technology.
Skin cancer is the most common cancer in the U.S. Nearly 10,000 Americans are diagnosed with the disease every day, and one in five will develop skin cancer in their lifetime.
Vita's patented AURA device can identify skin cancer in less than two seconds — the result of twenty years of research & development and more than twenty million dollars in investment.
FDA approval for Vita's device is pending and the company has completed peer-reviewed studies at Harvard and the University of British Columbia.